ProShares Ultra NASDAQ Biotechnology
24 hedge funds and large institutions have $6.47M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
5
Closed
4
Calls
$764K
Puts
$972K
Net Calls
-$208K
Net Calls Change
-$24K